Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Laboratory and Benchtop Performance of a Mealtime Insulin-Delivery System.

Dreon DM, Hannon TM, Cross B, Carter BJ, Mercer NS, Nguyen JH, Tran A, Melendez PA, Morales N, Nelson JE, Tan MH.

J Diabetes Sci Technol. 2018 Jul;12(4):817-827. doi: 10.1177/1932296818760633. Epub 2018 Feb 28.

2.

Authors' Response to Jesse D. Riordan, Hum Gene Ther 2017;28:375-376; DOI: 10.1089/hum.2017.045.

Srivastava A, Carter BJ.

Hum Gene Ther. 2017 May;28(5):376-377. doi: 10.1089/hum.2017.050. No abstract available.

PMID:
28498777
3.

AAV Infection: Protection from Cancer.

Srivastava A, Carter BJ.

Hum Gene Ther. 2017 Apr;28(4):323-327. doi: 10.1089/hum.2016.147. Epub 2016 Nov 10.

4.

Idiopathic spinal cord herniation: an imaging diagnosis with a significant delay.

Carter BJ, Griffith BD, Schultz LR, Abdulhak MM, Newman DS, Jain R.

Spine J. 2015 Sep 1;15(9):1943-8. doi: 10.1016/j.spinee.2015.04.013. Epub 2015 Apr 6.

PMID:
25857588
5.

Transoral incisionless fundoplication: 2-year results from the prospective multicenter U.S. study.

Bell RC, Barnes WE, Carter BJ, Sewell RW, Mavrelis PG, Ihde GM, Hoddinott KM, Fox MA, Freeman KD, Gunsberger T, Hausmann MG, Dargis D, DaCosta Gill B, Wilson E, Trad KS.

Am Surg. 2014 Nov;80(11):1093-105.

PMID:
25347499
6.

The RD parent empowerment program creates measurable change in the behaviors of low-income families and children: an intervention description and evaluation.

Hand RK, Birnbaum AS, Carter BJ, Medrow L, Stern E, Brown K.

J Acad Nutr Diet. 2014 Dec;114(12):1923-31. doi: 10.1016/j.jand.2014.08.014. Epub 2014 Oct 7.

PMID:
25300224
7.

Comparative genomics reveals surprising divergence of two closely related strains of uncultivated UCYN-A cyanobacteria.

Bombar D, Heller P, Sanchez-Baracaldo P, Carter BJ, Zehr JP.

ISME J. 2014 Dec;8(12):2530-42. doi: 10.1038/ismej.2014.167. Epub 2014 Sep 16.

8.

Charting a clear path: the ASGCT Standardized Pathways Conference.

Kiem HP, Baum C, Bushman FD, Byrne BJ, Carter BJ, Cavagnaro J, Malech HL, Mendell JR, Naldini LM, Sorrentino BP, Williams DA, Flotte TR.

Mol Ther. 2014 Jul;22(7):1235-1238. doi: 10.1038/mt.2014.95. No abstract available.

9.

Univariate and multivariate analyses of preoperative factors influencing symptomatic outcomes of transoral fundoplication.

Bell RC, Fox MA, Barnes WE, Mavrelis PG, Sewell RW, Carter BJ, Ihde GM, Trad KS, Dargis D, Hoddinott KM, Freeman KD, Gunsberger T, Hausmann MG, Gill BD, Wilson E.

Surg Endosc. 2014 Oct;28(10):2949-58. doi: 10.1007/s00464-014-3557-z. Epub 2014 May 31.

10.

Genetic diversity of the unicellular nitrogen-fixing cyanobacteria UCYN-A and its prymnesiophyte host.

Thompson A, Carter BJ, Turk-Kubo K, Malfatti F, Azam F, Zehr JP.

Environ Microbiol. 2014 Oct;16(10):3238-49. doi: 10.1111/1462-2920.12490. Epub 2014 May 21.

11.

The effects of transoral incisionless fundoplication on chronic GERD patients: 12-month prospective multicenter experience.

Wilson EB, Barnes WE, Mavrelis PG, Carter BJ, Bell RC, Sewell RW, Ihde GM, Dargis D, Hoddinott KM, Shughoury AB, Gill BD, Fox MA, Turgeon DG, Freeman KD, Gunsberger T, Hausmann MG, Leblanc KA, Deljkich E, Trad KS.

Surg Laparosc Endosc Percutan Tech. 2014 Feb;24(1):36-46. doi: 10.1097/SLE.0b013e3182a2b05c.

PMID:
24487156
12.

Quantifying the distribution of nanodiamonds in pre-Younger Dryas to recent age deposits along Bull Creek, Oklahoma panhandle, USA.

Bement LC, Madden AS, Carter BJ, Simms AR, Swindle AL, Alexander HM, Fine S, Benamara M.

Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1726-31. doi: 10.1073/pnas.1309734111. Epub 2014 Jan 21.

13.

Non-cyanobacterial nifH phylotypes in the North Pacific Subtropical Gyre detected by flow-cytometry cell sorting.

Bombar D, Turk-Kubo KA, Robidart J, Carter BJ, Zehr JP.

Environ Microbiol Rep. 2013 Oct;5(5):705-15. doi: 10.1111/1758-2229.12070. Epub 2013 Jun 6.

PMID:
24115621
14.

Genomic deletions disrupt nitrogen metabolism pathways of a cyanobacterial diatom symbiont.

Hilton JA, Foster RA, Tripp HJ, Carter BJ, Zehr JP, Villareal TA.

Nat Commun. 2013;4:1767. doi: 10.1038/ncomms2748.

15.

Unicellular cyanobacterium symbiotic with a single-celled eukaryotic alga.

Thompson AW, Foster RA, Krupke A, Carter BJ, Musat N, Vaulot D, Kuypers MM, Zehr JP.

Science. 2012 Sep 21;337(6101):1546-50.

16.

A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.

Bell RC, Mavrelis PG, Barnes WE, Dargis D, Carter BJ, Hoddinott KM, Sewell RW, Trad KS, DaCosta Gill B, Ihde GM.

J Am Coll Surg. 2012 Dec;215(6):794-809. doi: 10.1016/j.jamcollsurg.2012.07.014. Epub 2012 Aug 29.

PMID:
22939637
17.

Taking microarrays to the field: differential hepatic gene expression of caged fathead minnows from Nebraska watersheds.

Sellin Jeffries MK, Mehinto AC, Carter BJ, Denslow ND, Kolok AS.

Environ Sci Technol. 2012 Feb 7;46(3):1877-85. doi: 10.1021/es2039097. Epub 2012 Jan 12.

PMID:
22165990
18.

Adeno-associated viral vectors for hereditary emphysema; progressing along the clinical development highway.

Carter BJ.

Hum Gene Ther. 2011 Oct;22(10):1175-7. doi: 10.1089/hum.2011.2524. No abstract available.

PMID:
22044094
19.

Gene set enrichment analysis of microarray data from Pimephales promelas (Rafinesque), a non-mammalian model organism.

Thomas MA, Yang L, Carter BJ, Klaper RD.

BMC Genomics. 2011 Jan 26;12:66. doi: 10.1186/1471-2164-12-66.

20.

Evidence-based decision-making: practical issues in the appraisal of evidence to inform policy and practice.

Carter BJ.

Aust Health Rev. 2010 Nov;34(4):435-40. doi: 10.1071/AH09778.

PMID:
21108904
21.

Effects of brevetoxin exposure on the immune system of loggerhead sea turtles.

Walsh CJ, Leggett SR, Carter BJ, Colle C.

Aquat Toxicol. 2010 May 10;97(4):293-303. doi: 10.1016/j.aquatox.2009.12.014. Epub 2009 Dec 21.

PMID:
20060602
22.

Agrichemicals in Nebraska, USA, watersheds: occurrence and endocrine effects.

Sellin MK, Snow DD, Schwarz M, Carter BJ, Kolok AS.

Environ Toxicol Chem. 2009 Nov;28(11):2443-8. doi: 10.1897/09-135.1.

PMID:
19604031
23.

Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.

Boudreau RL, McBride JL, Martins I, Shen S, Xing Y, Carter BJ, Davidson BL.

Mol Ther. 2009 Jun;17(6):1053-63. doi: 10.1038/mt.2009.17. Epub 2009 Feb 24.

24.

Redox modifier genes and pathways in amyotrophic lateral sclerosis.

Carter BJ, Anklesaria P, Choi S, Engelhardt JF.

Antioxid Redox Signal. 2009 Jul;11(7):1569-86. doi: 10.1089/ARS.2008.2414. Review.

25.

Increasing physical activity in preschool: a pilot study to evaluate animal trackers.

Williams CL, Carter BJ, Kibbe DL, Dennison D.

J Nutr Educ Behav. 2009 Jan-Feb;41(1):47-52. doi: 10.1016/j.jneb.2008.03.004.

PMID:
19161920
26.

The genomic transcriptional response of female fathead minnows (Pimephales promelas) to an acute exposure to the androgen, 17beta-trenbolone.

Dorts J, Richter CA, Wright-Osment MK, Ellersieck MR, Carter BJ, Tillitt DE.

Aquat Toxicol. 2009 Jan 18;91(1):44-53. doi: 10.1016/j.aquatox.2008.10.002. Epub 2008 Oct 14.

27.

Gene expression changes in bottlenose dolphin, Tursiops truncatus, skin cells following exposure to methylmercury (MeHg) or perfluorooctane sulfonate (PFOS).

Mollenhauer MA, Carter BJ, Peden-Adams MM, Bossart GD, Fair PA.

Aquat Toxicol. 2009 Jan 18;91(1):10-8. doi: 10.1016/j.aquatox.2008.09.013. Epub 2008 Oct 4.

PMID:
19010555
28.

Globally distributed uncultivated oceanic N2-fixing cyanobacteria lack oxygenic photosystem II.

Zehr JP, Bench SR, Carter BJ, Hewson I, Niazi F, Shi T, Tripp HJ, Affourtit JP.

Science. 2008 Nov 14;322(5904):1110-2. doi: 10.1126/science.1165340.

29.

GROWTH AND CARBON CONTENT OF THREE DIFFERENT-SIZED DIAZOTROPHIC CYANOBACTERIA OBSERVED IN THE SUBTROPICAL NORTH PACIFIC(1).

Goebel NL, Edwards CA, Carter BJ, Achilles KM, Zehr JP.

J Phycol. 2008 Oct;44(5):1212-20. doi: 10.1111/j.1529-8817.2008.00581.x. Epub 2008 Sep 17.

PMID:
27041718
30.

Effect of gene therapy on visual function in Leber's congenital amaurosis.

Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, Petersen-Jones S, Bhattacharya SS, Thrasher AJ, Fitzke FW, Carter BJ, Rubin GS, Moore AT, Ali RR.

N Engl J Med. 2008 May 22;358(21):2231-9. doi: 10.1056/NEJMoa0802268. Epub 2008 Apr 27.

31.

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi.

McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, Gilmore BL, Burstein H, Peluso RW, Polisky B, Carter BJ, Davidson BL.

Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5868-73. doi: 10.1073/pnas.0801775105. Epub 2008 Apr 8.

32.

Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial.

Moss RB, Milla C, Colombo J, Accurso F, Zeitlin PL, Clancy JP, Spencer LT, Pilewski J, Waltz DA, Dorkin HL, Ferkol T, Pian M, Ramsey B, Carter BJ, Martin DB, Heald AE.

Hum Gene Ther. 2007 Aug;18(8):726-32.

PMID:
17685853
33.

Development and validation of a 2,000-gene microarray for the fathead minnow (Pimephales promelas).

Larkin P, Villeneuve DL, Knoebl I, Miracle AL, Carter BJ, Liu L, Denslow ND, Ankley GT.

Environ Toxicol Chem. 2007 Jul;26(7):1497-506.

PMID:
17665692
34.

A graphical systems model to facilitate hypothesis-driven ecotoxicogenomics research on the teleost brain-pituitary-gonadal axis.

Villeneuve DL, Larkin P, Knoebl I, Miracle AL, Kahl MD, Jensen KM, Makynen EA, Durhan EJ, Carter BJ, Denslow ND, Ankley GT.

Environ Sci Technol. 2007 Jan 1;41(1):321-30.

PMID:
17265966
35.

Comparative genomics of DNA fragments from six Antarctic marine planktonic bacteria.

Grzymski JJ, Carter BJ, DeLong EF, Feldman RA, Ghadiri A, Murray AE.

Appl Environ Microbiol. 2006 Feb;72(2):1532-41.

36.

Workshop on long-term follow-up of participants in human gene transfer research.

Nyberg K, Carter BJ, Chen T, Dunbar C, Flotte TR, Rose S, Rosenblum D, Simek SL, Wilson C.

Mol Ther. 2004 Dec;10(6):976-80. No abstract available.

37.

Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy.

Flotte TR, Schwiebert EM, Zeitlin PL, Carter BJ, Guggino WB.

Hum Gene Ther. 2005 Aug;16(8):921-8.

PMID:
16076250
38.

Single and multiple congenic strains for hydrocephalus in the H-Tx rat.

Jones HC, Chen GF, Yehia BR, Carter BJ, Akins EJ, Wolpin LC.

Mamm Genome. 2005 Apr;16(4):251-61.

39.
40.

Adeno-associated virus vectors in clinical trials.

Carter BJ.

Hum Gene Ther. 2005 May;16(5):541-50. Review. No abstract available.

PMID:
15916479
41.

Using media messaging to promote healthful eating and physical activity among urban youth.

Carter BJ, Birnbaum AS, Hark L, Vickery B, Potter C, Osborne MP.

J Nutr Educ Behav. 2005 Mar-Apr;37(2):98-9. No abstract available.

PMID:
15882488
42.

Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective.

Carter BJ.

Mol Ther. 2004 Dec;10(6):981-9. Review. No abstract available.

43.

Genetic analysis of inherited hydrocephalus in a rat model.

Jones HC, Yehia B, Chen GF, Carter BJ.

Exp Neurol. 2004 Nov;190(1):79-90.

PMID:
15473982
44.

AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of alpha-galactosidase A and the induction of immune tolerance in Fabry mice.

Ziegler RJ, Lonning SM, Armentano D, Li C, Souza DW, Cherry M, Ford C, Barbon CM, Desnick RJ, Gao G, Wilson JM, Peluso R, Godwin S, Carter BJ, Gregory RJ, Wadsworth SC, Cheng SH.

Mol Ther. 2004 Feb;9(2):231-40.

45.

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.

Flotte TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S, Conrad CK, Brass-Ernst L, Humphries M, Sullivan K, Wetzel R, Taylor G, Carter BJ, Guggino WB.

Hum Gene Ther. 2003 Jul 20;14(11):1079-88.

PMID:
12885347
46.

Nonclinical toxicology in support of licensure of gene therapies. Arlington, VA, USA, March 13-14, 2003.

Frederickson RM, Carter BJ, Pilaro AM.

Mol Ther. 2003 Jul;8(1):8-10. No abstract available.

47.

Characteristics of hydrocephalus expression in the LEW/Jms rat strain with inherited disease.

Jones HC, Carter BJ, Morel L.

Childs Nerv Syst. 2003 Jan;19(1):11-8. Epub 2002 Dec 13.

PMID:
12541080
48.

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.

Wagner JA, Nepomuceno IB, Messner AH, Moran ML, Batson EP, Dimiceli S, Brown BW, Desch JK, Norbash AM, Conrad CK, Guggino WB, Flotte TR, Wine JJ, Carter BJ, Reynolds TC, Moss RB, Gardner P.

Hum Gene Ther. 2002 Jul 20;13(11):1349-59.

PMID:
12162817
49.

The frequency of inherited hydrocephalus is influenced by intrauterine factors in H-Tx rats.

Jones HC, Depelteau JS, Carter BJ, Somera KC.

Exp Neurol. 2002 Jul;176(1):213-20.

PMID:
12093098
50.

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease.

Aitken ML, Moss RB, Waltz DA, Dovey ME, Tonelli MR, McNamara SC, Gibson RL, Ramsey BW, Carter BJ, Reynolds TC.

Hum Gene Ther. 2001 Oct 10;12(15):1907-16.

PMID:
11589832

Supplemental Content

Loading ...
Support Center